World Orphan Drug Congress USA brings together industry leaders from big pharma, biotechs, government and research organizations to address the opportunities and challenges for the commercialization of drugs to treat rare diseases. Register now to translate your novel treatments into commercially marketable therapies.
Come to the World Orphan Drug Congress USA and learn:
- How to market your orphan drugs efficiently
- How to get easier access to your niche and widespread patients
- How to complete pre-clinical and clinical trials with a very widespread patient group
- How to gain market approval from the US FDA
- How to raise capital and get funding
You’ll come away with great new ideas to do better business. You’ll make new contacts, and maximize your presence in the orphan drug space.
An unrivalled speaker line-up including:
- US FDA
- NIH
- Shire Human Genetic Therapies
- Genzyme
- BioMarin Pharmaceutical
- Pfizer
- GlaxoSmithKline
- Kakkis EveryLife Foundation
- Lundbeck
- Lilly
- Novartis
- United Therapeutics
- AesRx
- Longitude Capital
- Prosensa
- Palo Alto Investors
The World Orphan Drug Congress USA focus:
- Global trends in orphan drug development
- Biotech commercial strategies
- Big Pharma strategies
- Clinical development strategies
- Patient partnerships
- Funding orphan drug R&D
- Expanding product indications
- Making patients the priority
If you need to know the latest innovations in these areas you must attend.
